Sil Suhasini, Kaur Daljit, Negi Gita, Jain Ashish, Nath Uttam Kumar
Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh, India.
Indian J Hematol Blood Transfus. 2025 Jan;41(1):127-136. doi: 10.1007/s12288-024-01805-y. Epub 2024 Jun 17.
The study aimed to find out the correlation of positive direct antiglobulin test (DAT) with features of autoimmune hemolysis in patients presenting to a tertiary care center in Northern India. Patient history, lab findings, and immune-hematological findings which can influence the management of patients with auto-immune hemolytic anemia were studied. DAT helps to differentiate immune hemolysis from non-immune hemolysis in patients with hemolytic anemia. A prospective study over 18 months was performed on DAT-positive samples of patients showing features of auto-immune hemolysis. The laboratory markers of hemolysis were correlated with immune-hematological studies like elution-adsorption, antibody specificity, and titer. Out of 1371 requests received for Immuno-hematological workup of patients with hemolysis, 92 (6.71%) met the inclusion criteria. Thirty (32.6%) patients were diagnosed with primary (Idiopathic) Auto-immune Hemolytic Anemia (AIHA), and the remaining 62(67.3%) patients had secondary AIHA. The gender distribution in primary AIHA was male: female as 1:2.7, while in secondary AIHA it was observed as male: female to be 1:1.3.The median age for primary AIHA was found to be 23.7 years (range 1 year to 48 years), and for secondary AIHA it was found to be 44.6 years (range 2 to 85 years). Of all AIHA patients tested, 85.8% showed the presence of warm autoantibodies in their sera while 7.6% had mixed-type AIHA and the remaining 6.5% had cold autoantibodies. The study highlights a strong association between higher strength of DAT positivity, multiple antibodies/immunoglobulins with complements coating red cells, and a higher titer of IgG and IgG1 & IgG3 subclass with the severity of hemolysis.
该研究旨在找出在印度北部一家三级医疗中心就诊的患者中,直接抗球蛋白试验(DAT)阳性与自身免疫性溶血特征之间的相关性。研究了患者病史、实验室检查结果以及可能影响自身免疫性溶血性贫血患者治疗的免疫血液学检查结果。DAT有助于区分溶血性贫血患者的免疫性溶血和非免疫性溶血。对显示自身免疫性溶血特征的患者的DAT阳性样本进行了为期18个月的前瞻性研究。溶血的实验室指标与洗脱吸附、抗体特异性和滴度等免疫血液学研究相关。在收到的1371例溶血患者免疫血液学检查申请中,92例(6.71%)符合纳入标准。30例(32.6%)患者被诊断为原发性(特发性)自身免疫性溶血性贫血(AIHA),其余62例(67.3%)患者为继发性AIHA。原发性AIHA的性别分布为男性:女性为1:2.7,而继发性AIHA中男性:女性为1:1.3。原发性AIHA的中位年龄为23.7岁(范围1岁至48岁),继发性AIHA的中位年龄为44.6岁(范围2岁至85岁)。在所有接受检测的AIHA患者中,85.8%的患者血清中存在温自身抗体,7.6%为混合型AIHA,其余6.5%为冷自身抗体。该研究强调了DAT阳性强度较高、多种抗体/免疫球蛋白与补体包被红细胞以及IgG和IgG1及IgG3亚类滴度较高与溶血严重程度之间的密切关联。